Hisun CEO said the following about Celsion and The

Hisun CEO said the following about Celsion and Thermodox: He called it the new SOC in China He just said that the SOC in China for treatment of HCC will be THERMODOX....>>>" up until now, there has not been any standard of care for treating HCC in China"<<< "up until NOW" Hisun-Celsion deal. Mr. Hua Bai, CEO and Chairman of Hisun, stated, "We are extremely excited to pursue this arrangement with Celsion. Hisun is well positioned to provide ThermoDox® —potentially one of the most important and innovative drugs to treat HCC to patients in China, the world's largest market. China is one of the countries with the highest HCC incidence and mortality and, up until now, there has not been any standard of care for treating HCC in China. This joint effort will most likely facilitate the local manufacturing and commercial launch in China, thereby providing physicians with more options for better care and prolonging the survival of HCC patients. In the meantime, we are also hopeful that this collaboration will enable Hisun to increase its focus on more innovative drugs. Given the fact that we are a leading Chinese pharmaceutical company with international standards of R&D and manufacturing technology, Hisun will seek to manufacture and supply the global markets, along with distribution exclusivity in Greater China. This venture will help spearhead Hisun's globalization in manufacturing and commercialization capabilities. He just called Thermodox the standard of care for treating HCC in China..... http://www.marketwatch.com/story/celsion-corp...2013-01-22